Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Inhibrx Biosciences Inc.
Swot
Inhibrx Biosciences Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Inhibrx Biosciences Inc. has 15 Strengths, 7 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(7)
Opportunity
(0)
Threats
(3)
Others
(0)
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent Highest Return Stocks over Five Years
PE less than Industry PE
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 10 Years
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Companies with reducing Debt
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Red Flag: Companies with weak Sloan Ratio
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Top Losers
Declining Net Cash Flow : Companies not able to generate net cash
Top Losers
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
